Peter Mueller, Director at BioXcel Therapeutics, Inc. (BTAI), bought 8,795 shares at $5.01 ($44K) on 2018-12-06, disclosed to the SEC on 2018-12-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 1,295 | $6K | 14.7% |
| 2 | $5.01 | 100 | $501 | 1.1% |
| 3 | $5.00 | 495 | $2K | 5.6% |
| 4 | $5.01 | 6,905 | $35K | 78.5% |
| Total | $5.01 avg | 8,795 | $44K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |
| VRTX | SELL | 2014-05-16 | $506K | — | Filing → |